calator design: the peptide quinoline conjugate (PQC). A
solid-phase synthesis scheme is reported for the preparation
of 2-phenylquinolines with peptide substituents at the 4- and
8-positions. Furthermore, the ability of the intercalator to
π-stack can be readily modulated by altering the polarity of
the π-aromatic system through substitution of the 2-phenyl
group. The RNA binding properties of a prototypical PQC
are also evaluated.
Scheme 1a
To generate quinoline-based threading intercalator pep-
tides, we prepared compounds 1 and 2, each with an Alloc-
protected 4-aminobenzylamine appendage at the quinoline
4-position and a carboxyl group at the 8-position (Figure
1). A phenyl group is present at position 2, since 2-phenyl-
a (a) (i) CH3SO3H/benzene reflux, (ii) Ph2O/255 °C; (b) PPh3/
NBS/CH3CN reflux; (c) allyl 4-aminobenzyl-amino carbamate12/
CH3CN reflux; (d) LiOH‚H2O/THF-H2O rt.
Figure 1. Amino acids synthesized for incorporation into peptide
quinoline conjugates via SPPS.
weakly nucleophilic aniline derivatives.18 Indeed, compound
4 is readily converted to 4-anilino derivative 5 in acetonitrile
at reflux in excellent yield. Saponification of the methyl ester
gave N-Alloc-protected amino acid 1 ready for activation
and coupling in SPPS. This same strategy can be extended
to prepare quinoline amino acids with a substituted phenyl
group of varying π-system polarity, as indicated by the
synthesis of nitro compound 2 (Scheme 1). The synthesis of
2 was initiated by condensation of ethyl(4-nitrobenzoyl)-
acetate and methylanthranilate followed by cyclization to
give quinolone 6. Bromination to 7, substitution with Alloc-
protected amine to give 8, and saponification produced 2-(4-
nitrophenyl)quinoline amino acid 2.
To demonstrate that these 2-phenylquinoline amino acids
can be used in SPPS, the peptide sequence N-Abu-Ser-Val-
PheQ-Arg-C was prepared, where Abu is aminobutyric acid
and PheQ refers to the 4,8-disubstituted 2-phenylquinoline
amino acid. Amino acid 1 was activated as the N-hydroxy-
succinimide (NHS) ester and coupled to the solid-supported
primary amino group of Pbf-protected arginine. The Alloc
group was removed using Pd(PPh3)4/PhSiH3 in CH2Cl2 at
room temperature for 30 min to reveal the benzylamine for
subsequent elaboration by peptide synthesis.19 The additional
amino acid residues were introduced via standard protocols.
Upon completion of the solid-phase synthesis, the peptide
was released and the side chains were deprotected by
treatment of the resin with TFA/TIS/PhOH/H2O (88:5:5:2)
to give peptide 9 (Figure 2). The structure of 9 was confirmed
by fast atom bombardment and electrospray ionization mass
spectrometry.
quinolines are known intercalators. Furthermore, the π-stack-
ing ability of the 2-phenyl group present in compound 2 is
modulated by the polarizing nitro substituent. In analogy to
the acridine-containing amino acid previously described by
us, these compounds are likely to be compatible with solid-
phase peptide synthesis (SPPS) with Fmoc-protected amino
acids.12,13 2-Phenyl-4-aminoquinoline derivatives and 2-
phenylquinoline-8-carboxamides have been shown to bind
nucleic acids by intercalation.14,15 However, there are no prior
reports of 2-phenylquinolines simultaneously modified at
positions 4 and 8 in this manner. This substitution pattern
creates molecules with substituents on opposite edges of the
quinoline heterocycle and, thus, potential threading interca-
lators.
Our synthesis of 1 begins with 8-methoxycarbonyl-2-
phenyl-4(1H)-quinolone 3, which is prepared as described
by Denny via condensation of methyl anthranilate and
ethylbenzoyl acetate followed by thermal cyclization of the
condensation product (Scheme 1).16 Bromination of 3 by
treatment with triphenylphosphine and N-bromosuccinimide
in acetonitrile gave 4 in good yield.17 Given our recent
experience with simple substitution reactions involving
acetyl-protected bromopurine ribonucleosides, we anticipated
that bromoquinoline 4 would react selectively at the 4-posi-
tion under mild conditions with nitrogen nucleophiles, even
(13) Carlson, C. B.; Beal, P. A. Org. Lett. 2000, 2, 1465-1468.
(14) Zhou, M.; Janda, L.; Nguyen, J.; Strekowski, L.; Wilson, W. D.
Biopolymers 1994, 34, 61-73.
The threading peptide N-Abu-Ser-Val-Acr-Arg-C (10),
where Acr is a 4,9-disubstituted acridine amino acid, binds
(15) Denny, W. A.; Atwell, G. J.; Baguley, B. C. Anti-Cancer Drug Des.
1987, 2, 263-270.
(16) Atwell, G. J.; Baguley, B. C.; Denny, W. A. J. Med. Chem. 1989,
32, 396-401.
(18) Ve´liz, E. A.; Beal, P. A. J. Org. Chem. 2001, 66, 8592-8598.
(19) Thieriet, N.; Alsina, J.; Giralt, E.; Guibe´, F.; Albericio, F.
Tetrahedron Lett. 1997, 38, 7275-7278.
(17) Sugimoto, O.; Mori, M.; Tanji, K.-i. Tetrahedron Lett. 1999, 40,
7477-7478.
64
Org. Lett., Vol. 6, No. 1, 2004